Sanara MedTech (SMTI) Cost of Revenue (2010 - 2026)

Sanara MedTech's Cost of Revenue history runs 16 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• Quarterly Cost of Revenue rose 4.83% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (down 5.88% YoY) and the FY2025 annual result came in at $7.5 million, down 7.6% from the prior year.
• Cost of Revenue was $1.9 million for Q1 2026 at Sanara MedTech, up from $1.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.4 million in Q4 2022 and bottomed at $805081.0 in Q1 2022.
• A 5-year average of $1.9 million and a median of $1.9 million in 2026 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 330.55% — and 2023, when it decreased 24.52%.
• Sanara MedTech's Cost of Revenue stood at $2.4 million in 2022, then dropped by 24.52% to $1.8 million in 2023, then climbed by 25.78% to $2.2 million in 2024, then declined by 16.66% to $1.9 million in 2025, then advanced by 2.62% to $1.9 million in 2026.
• Business Quant data shows SMTI's Cost of Revenue at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.